[go: up one dir, main page]

Pirrung et al., 2003 - Google Patents

High-Throughput Catch-and-Release Synthesis of Oxazoline Hydroxamates. Structure− Activity Relationships in Novel Inhibitors of Escherichia c oli LpxC: In Vitro …

Pirrung et al., 2003

Document ID
6271097584046153578
Author
Pirrung M
Tumey L
McClerren A
Raetz C
Publication year
Publication venue
Journal of the American Chemical Society

External Links

Snippet

LpxC is a zinc amidase that catalyses the second step of lipid A biosynthesis in Gram- negative bacteria. Oxazolines incorporating a hydroxamic acid, which is believed to coordinate to the single essential zinc ion, at the 4-position are known inhibitors of this …
Continue reading at pubs.acs.org (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions

Similar Documents

Publication Publication Date Title
Pirrung et al. High-Throughput Catch-and-Release Synthesis of Oxazoline Hydroxamates. Structure− Activity Relationships in Novel Inhibitors of Escherichia c oli LpxC: In Vitro Enzyme Inhibition and Antibacterial Properties
Pirrung et al. Inhibition of the antibacterial target UDP-(3-O-acyl)-N-acetylglucosamine deacetylase (LpxC): isoxazoline zinc amidase inhibitors bearing diverse metal binding groups
Panchaud et al. Discovery and optimization of isoquinoline ethyl ureas as antibacterial agents
Wei et al. Bench-stable 5-stannyl triazoles by a copper (I)-catalyzed interrupted click reaction: bridge to trifluoromethyltriazoles and trifluoromethylthiotriazoles
Apfel et al. Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents
Brown et al. Potent inhibitors of LpxC for the treatment of Gram-negative infections
Kline et al. Potent, Novel in Vitro Inhibitors of the Pseudomonas a eruginosa Deacetylase LpxC
Liang et al. Synthesis, structure, and antibiotic activity of aryl-substituted LpxC inhibitors
Mossetti et al. Efficient synthesis of α-ketoamides via 2-acyl-5-aminooxazoles by reacting acyl chlorides and α-isocyanoacetamides
Liu et al. Discovery of highly selective and potent HDAC3 inhibitors based on a 2-substituted benzamide zinc binding group
Hu et al. Macrocyclic inhibitors for peptide deformylase: a structure− activity relationship study of the ring size
Pemberton et al. Synthesis and functionalization of cyclic sulfonimidamides: a novel chiral heterocyclic carboxylic acid bioisostere
García-Reynaga et al. Decarbonylative approach to the synthesis of enamides from amino acids: stereoselective synthesis of the (Z)-aminovinyl-D-cysteine unit of mersacidin
Ragno et al. 3-(4-Aroyl-1-methyl-1 H-pyrrol-2-yl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 3. Discovery of novel lead compounds through structure-based drug design and docking studies
Liu et al. Stereoselective syntheses of 4-oxa diaminopimelic acid and its protected derivatives via aziridine ring opening
Gaffney et al. Synthesis of c-di-GMP analogs with thiourea, urea, carbodiimide, and guanidinium linkages
Luo et al. Discovery and Structural Modification of Inhibitors of Methionine Aminopeptidases from Escherichia c oli and Saccharomyces c erevisiae
Avenoza et al. Stereoselective synthesis of orthogonally protected α-methylnorlanthionine
Charrier et al. Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression
Okamoto et al. Total synthesis and biological evaluation of pacidamycin D and its 3′-hydroxy analogue
Kwon et al. Synthesis of bicyclic guanidines via cascade hydroamination/Michael additions of mono-N-acryloylpropargylguanidines
Deng et al. Late-stage functionalization of platensimycin leading to multiple analogues with improved antibacterial activity in vitro and in vivo
Gharpure et al. Lewis-Acid-Catalyzed Reductive Hydroalkoxylation of Propargylic N-Hydroxylamines Gives Stereoselective Access to Isoxazolidines
Panchaud et al. Optimization of LpxC inhibitor lead compounds focusing on efficacy and formulation for high dose intravenous administration
Elwood et al. Functionalized tetrazoles as latent active esters in the synthesis of amide bonds